Recent Updates
Recently added Catalysts

dry gauze, The Prevena Incision Management System

Phase 3

Negative-Pressure Wound Therapy | Unknown | Other |3M Company|Last Updated: Mar 18, 2025

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment583
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02682316Negative Pressure Wound Therapy in Post-Operative Incision ManagementPHASE3 COMPLETED 583Feb 1, 2016Jan 25, 2024Mar 18, 202510 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Number of Post-op Wound Complications
30 days +/- 5 days after surgery

Incidence of inpatient post-operative wound complications will be documented through the use of an inpatient data collection sheet. Incidence of outpatient post-operative wound complication will be documented through the use of an outpatient data collection sheet that will be completed by a provider at the time of the routine post-operative follow-up visit, which will occur at 30 days +/- 5 days after the day of surgery as well as through ongoing documentation of events as elicited through the institution's standard reporting system to collect information on enrolled patients.

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
usual standard dry gauze used for wound managementACTIVE_COMPARATORPatients who are randomized to the standard dry gauze arm will have the standard dry gauze placed at time of wound closure. Their dressing will be removed on post-operative day 2 as per routine departmental practice.
Prevena Negative Pressure Wound Therapy System (NPWT)EXPERIMENTALPatients who are randomized to the Prevena Therapy System arm will have the Prevena Incision Management System device placed at time of wound closure. The device will be removed on day of discharge from the hospital or post-operative day 7, whichever comes first.
Interventions
NameTypeDescription
dry gauzeOTHER -
The Prevena Incision Management SystemDEVICE -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexFEMALE
Healthy VolunteersNo
Study Sites10

Inclusion Criteria: Criteria for Eligibility Prior to Surgery: * Women of any BMI undergoing a laparotomy procedure for a presumed gynecologic malignancy, or morbidly obese (BMI ≥ 40) women undergoing a laparotomy for any indication * or women who are morbidly obese (BMI\>40) undergoing laparotomy...

Countries:United States
Unlock Eligibility Criteria